Johnson & Johnson
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
JNJ News
Nvidia said Monday that it was partnering with Johnson & Johnson MedTech to use the power of AI to help doctors perform surgery. J&J MedTech is in 80% of the wo...
Johnson & Johnson on Monday announced it is working with Nvidia to develop and scale new artificial intelligence applications for surgery. J&J's MedTech unit a...
Johnson & Johnson (JNJ) closed at $156.76 in the latest trading session, marking a -0.9% move from the prior day. The stock's performance was behind the S&P 500...
Analyst ratings
57%
of 23 ratingsMore JNJ News
Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the s...
Over the past year, many Johnson & Johnson (NYSE:JNJ) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whethe...
Johnson & Johnson (NYSE: JNJ) is one of the leading and most recognizable names in healthcare. It generates billions in revenue and profit every year and its pr...
Johnson & Johnson announced that the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee, or ODAC, recommends Carvykti for the treatment of adu...
Loading... Loading... The FDA granted accelerated approval on Thursday to Bristol Myers Squibb Co.’s BMY of Breyanzi (lisocabtagene maraleucel, liso-cel), a CD...
An FDA advisory committee voted 11-0 in favor of expanding the label of Carvykti, finding that the benefits of the Johnson & Johnson treatment outweigh risks in...
For Immediate Release Chicago, IL – March 14, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...